XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Parent Company Financials. (Tables)
9 Months Ended
Sep. 30, 2021
Condensed Financial Information Disclosure [Abstract]  
Schedule of parent company financial statements
   September 30,
2021
   December 31,
2020
 
ASSETS        
Current Assets:        
Cash and cash equivalents  $7,038   $25,632 
Receivables from subsidiaries   23,165    15,548 
Other current assets   891    1,836 
Total current assets   31,094    43,016 
           
Property and equipment, net   98    142 
Other Assets:          
Investments in subsidiaries   255,904    246,518 
Alto West, LLC receivable   27,592    42,649 
Right of use operating lease assets, net   2,773    2,985 
Other assets   796    1,088 
Total other assets   287,065    293,240 
Total Assets  $318,257   $336,398 
Current Liabilities:          
Accounts payable and accrued liabilities  $5,405   $2,001 
Accrued Alto Op Co. purchase   3,829    3,829 
Current portion of long-term debt   723    25,533 
Other current liabilities   332    473 
Total current liabilities   10,289    31,836 
           
Long-term debt, net of current portion   
    5,564 
Other liabilities   2,772    2,763 
Total Liabilities   13,061    40,163 
Stockholders’ Equity:          
Preferred stock   1    1 
Common and non-voting common stock   73    72 
Additional paid-in capital   1,036,608    1,036,638 
Accumulated other comprehensive loss   (3,878)   (3,878)
Accumulated deficit   (727,608)   (736,598)
Total Alto Ingredients, Inc. stockholders’ equity   305,196    296,235 
Total Liabilities and Stockholders’ Equity  $318,257   $336,398 

 

Schedule of statement of operations parent company
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2021   2020   2021   2020 
                 
Management fees from subsidiaries  $2,406   $2,802   $7,418   $8,928 
Selling, general and administrative expenses   3,105    3,305    12,149    12,990 
Loss from operations   (699)   (503)   (4,731)   (4,062)
Income from loan forgiveness   5,973    
    5,973    
 
Interest income (expense), net   42    (1,490)   (1,689)   (4,787)
Fair value adjustments   
    (6,856)   
    (7,497)
Other income (expense)   295    (41)   1,513    (203)
Income (loss) before benefit for income taxes   5,611    (8,890)   1,066    (16,549)
Benefit for income taxes   
    
    
    
 
Income (loss) before benefit for income taxes   5,611    (8,890)   1,066    (16,549)
Equity in income (losses) of subsidiaries   (8,743)   24,105    8,870    21,628 
Net income (loss)  $(3,132)  $15,215   $9,936   $5,079 

 

Schedule of statement of cash flows parent company
   For the Nine Months Ended
September 30,
 
   2021   2020 
Operating Activities:        
Net income  $9,936   $5,079 
Adjustments to reconcile net income to cash used in operating activities:          
Equity in (income) losses of subsidiaries   (8,870)   (21,628)
Income from loan forgiveness   (5,973)    
Fair value adjustments   
    7,497 
Depreciation   44    97 
Amortization of debt discounts   409    (173)
Changes in operating assets and liabilities:          
Accounts receivable   (7,617)   (288)
Other assets   1,449    1,184 
Accounts payable and accrued expenses   (2,213)   (19)
Accounts payable with subsidiaries   32     
Net cash used in operating activities  $(12,803)  $(8,251)
Investing Activities:          
Additions to property and equipment  $
   $
 
Net cash used in investing activities  $
   $
 
Financing Activities:          
Proceeds from issuances of common stock  $462   $5,296 
Proceeds from plant receivables   15,057    5,813 
Proceeds from warrant exercises       5,500 
Proceeds from long-term debt   
    5,973 
Payments on senior notes   (24,810)   (5,500)
Dividend from subsidiary   3,500    
 
Preferred stock dividend payments   
    
 
Net cash (used in) provided by financing activities  $(5,791)  $17,082 
Net change in cash and cash equivalents   (18,594)   8,831 
Cash and cash equivalents at beginning of period   25,632    4,985 
Cash and cash equivalents at end of period  $7,038   $13,816